Breaking News Instant updates and real-time market news.

SNAP

Snap

$26.91

-0.18 (-0.66%)

, JCI

Johnson Controls

$41.79

-0.27 (-0.64%)

10:29
03/06/17
03/06
10:29
03/06/17
10:29

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with an Underperform at Needham. 2. Johnson Controls (JCI) initiated with a Neutral at JPMorgan. 3. Regency Centers (REG) reinstated with an Equal Weight at Barclays. 4. Limbach Holding (LMB) initiated with a Buy at Roth Capital. 5. Enbridge (ENB) coverage resumed with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

SNAP

Snap

$26.91

-0.18 (-0.66%)

JCI

Johnson Controls

$41.79

-0.27 (-0.64%)

REG

Regency Centers

$66.86

-0.88 (-1.30%)

LMB

Limbach Holding

$14.10

0.1 (0.71%)

ENB

Enbridge

$41.06

0.105 (0.26%)

  • 06

    Mar

  • 06

    Mar

  • 06

    Mar

  • 12

    Mar

SNAP Snap
$26.91

-0.18 (-0.66%)

03/03/17
SUSQ
03/03/17
INITIATION
Target $22
SUSQ
Neutral
Snap initiated with a Neutral at Susquehanna
Susquehanna initiated Snap with a Neutral and a $22 price target.
03/03/17
03/03/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kite Pharma (KITE) downgraded to Hold from Buy at Stifel with analyst Thomas Shrader citing valuation. 2. Nutanix (NTNX) downgraded to Underweight at Morgan Stanley with analyst Katy Huberty saying she expects weaker results to continue given a more crowded market, slower OEM growth, fewer deals, and rising DRAM costs, among other reasons. 3. Snap (SNAP) downgraded to Underweight from Neutral at Atlantic Equities with analyst James Cordwell citing premium valuation and maintained its $14 price target. Cordwell believes the current multiple is unsustainable given unproven monetization potential, challenges re-accelerating user growth, and structurally lower profitability. 4. Kroger (KR) downgraded to Buy from Conviction Buy at Goldman with analyst Stephen Tanal saying the fourth quarter update demonstrated Kroger's competitive edge as eroded a bit and suggest the company is losing share to key competitor Wal-Mart (WMT), which accelerated its grocery business in Q4. 5. Southern Company (SO) downgraded to Hold from Buy at Argus with analyst Katelyn Bayone citing significant delays and cost overruns at its Kemper County plant. The analyst said Southern has now pushed back the commercial operation of the Kemper "clean-coal" plant to mid-March. The plant was originally scheduled to open in 2013, though the opening has been repeatedly pushed back. Bayone said the plant's economic viability has become less certain due to lower-than-expected natural gas prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/06/17
NEED
03/06/17
INITIATION
NEED
Underperform
Snap initiated with an Underperform at Needham
Needham analyst Laura Martin started recent IPO Snap (SNAP) with an Underperform rating. The company's total addressable market in is 80% smaller than Facebook's (FB), and it already has 50% penetration of this market in the U.S., Martin tells investors in a research note. Further, Snap has no ability to prevent copy-cats from stealing its best ideas, the analyst contends. She estimates the stock's value at $19-$23 per share.
03/03/17
03/03/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with a Neutral at Susquehanna. 2. GoPro (GPRO) initiated with a Sell and an $8 price target at Citi. 3. Wayfair (W) assumed with an Overweight at Piper Jaffray. 4. Paycom (PAYC) initiated with a Buy at Mizuho. 5. Restoration Hardware (RH) assumed with a Neutral at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
JCI Johnson Controls
$41.79

-0.27 (-0.64%)

03/06/17
JPMS
03/06/17
INITIATION
Target $44
JPMS
Neutral
Johnson Controls initiated with a Neutral at JPMorgan
JPMorgan analyst C. Stephen Tusa started Johnson Controls with a Neutral rating and $44 price target. The analyst sees a balanced risk/reward profile at current share levels.
12/12/16
GSCO
12/12/16
DOWNGRADE
Target $50
GSCO
Buy
Johnson Controls downgraded to Buy from Conviction Buy at Goldman
02/14/17
ARGS
02/14/17
DOWNGRADE
ARGS
Hold
Johnson Controls downgraded to Hold from Buy at Argus
Argus analyst John Eade downgraded Johnson Controls as he says that the company's revenue is growing more slowly than he had expected, while the stock's technicals indicate that it will decline further.
12/12/16
12/12/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CVS Health (CVS) downgraded to Hold from Buy at Jefferies with analyst Brian Tanquilut saying retail pharmacy market share losses are likely to limit the company's ability to post meaningful earnings upside over the next 12 months. 2. Johnson Controls (JCI) downgraded to Buy from Conviction Buy at Goldman. 3. Ophthotech (OPHT) downgraded to Neutral from Buy at Chardan, to Hold from Buy at SunTrust, and to Neutral from Overweight at JPMorgan. 4. Thermo Fisher (TMO) downgraded to Buy from Conviction Buy at Goldman with analyst Isaac Ro citing lack of near-term catalysts due to a more mixed end market outlook for 2017. 5. WebMD (WBMD) downgraded to Outperform from Strong Buy at Raymond James with analyst Nicholas Jensen citing recent share strength. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
REG Regency Centers
$66.86

-0.88 (-1.30%)

03/02/17
SBSH
03/02/17
INITIATION
Target $72
SBSH
Neutral
Regency Centers resumed with a Neutral at Citi
Citi analyst Michael Bilerman resumed coverage of Regency Centers with a Neutral rating and $72 price target.
03/06/17
LEHM
03/06/17
INITIATION
Target $72
LEHM
Equal Weight
Regency Centers reinstated with an Equal Weight at Barclays
Barclays analyst Linda Tsai reinstated Regency Centers with an Equal Weight rating and $72 price target.
03/02/17
03/02/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Regency Centers (REG) resumed with a Neutral at Citi. 2. Electronic Arts (EA) and Activision Blizzard (ATVI) initiated with an Outperform at William Blair. 3. Parker-Hannifin (PH) resumed with an Overweight at Morgan Stanley. 4. Gran Tierra (GTE) coverage resumed with a Buy at Canaccord. 5. Mammoth Energy (TUSK) initiated with an Overweight at Capital One. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/19/17
RHCO
01/19/17
UPGRADE
RHCO
Buy
Regency Centers upgraded to Buy from Hold at SunTrust
LMB Limbach Holding
$14.10

0.1 (0.71%)

12/22/16
DADA
12/22/16
INITIATION
Target $16.5
DADA
Buy
Limbach Holding initiated with a Buy at DA Davidson
DA Davidson analyst Brent Thielman initiated Limbach Holding with a Buy and a $16.50 price target. The analyst believes the combination of expanding non-residential building markets, as well internal growth initiatives aimed at share gains and expanding its profitable Services platform, should produce attractive top- and bottom-line growth in the next two years.
03/06/17
ROTH
03/06/17
INITIATION
Target $17.5
ROTH
Buy
Limbach Holding initiated with a Buy at Roth Capital
Roth Capital analyst Gerry Sweeney started Limbach Holding with a Buy rating and $17.50 price target saying that revenue should grow in excess of 10% for the next several years, and EBITDA margins should expand toward 5% then 7% longer term as higher value Services revenue increases, industry prices firm and the company leverages SG&A.
ENB Enbridge
$41.06

0.105 (0.26%)

01/30/17
01/30/17
DOWNGRADE
Target $22

Neutral
Enbridge Energy downgraded to Neutral at Mizuho
As previously reported, Mizuho downgraded Enbridge Energy (EEP) to Neutral and lowered its price target to $22 from $29. Analyst Brian Zarahn said parent Enbridge's (ENB) financial assistance on Line 3 project and acquisition of only part of Enbridge Energy's gas business does not go far enough to improve investor confidence.
01/30/17
01/30/17
UPGRADE
Target $8

Neutral
Midcoast Energy upgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst John Edwards upgraded Midcoast Energy (MEP) to Neutral from Underperform after the company announced that it has entered into a definitive merger agreement with Enbridge Energy Company, an indirect subsidiary of Enbridge (ENB), where Enbridge Energy Company will acquire all outstanding Midcoast Energy units for $8/each. The analyst believes the $8 per unit is "fair" given declining volumes and 2017 EBITDA which he forecasts to be down 32% year over year. Edwards also raised his price target on Midcoast Energy's to $8 from $6.
01/18/17
SBSH
01/18/17
INITIATION
SBSH
Neutral
Enbridge resumed with a Neutral at Citi
Citi analyst Faisel Khan resumed coverage of Enbridge with a Neutral rating and C$60 price target.
03/06/17
BMOC
03/06/17
INITIATION
BMOC
Outperform
Enbridge coverage resumed with an Outperform at BMO Capital
BMO Capital analyst Ben Pham is upbeat on Enbridge's acquisition of Spectra Energy. The analyst thinks the deal improves the company's growth outlook and balance sheet. He believes that the deal will cause the company's free cash flow and stock price to rise. Target to $72 from $58.

TODAY'S FREE FLY STORIES

RBGLY

Reckitt Benckiser

$20.53

0.04 (0.20%)

, MJN

Mead Johnson

$89.29

0.1 (0.11%)

15:32
05/28/17
05/28
15:32
05/28/17
15:32
Conference/Events
Mead Johnson to host special shareholder meeting »

Special Shareholder…

RBGLY

Reckitt Benckiser

$20.53

0.04 (0.20%)

MJN

Mead Johnson

$89.29

0.1 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

PHH

PHH Corp.

$13.58

0.06 (0.44%)

15:25
05/28/17
05/28
15:25
05/28/17
15:25
Conference/Events
PHH Corp. to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

TPIV

TapImmune

$3.71

-0.03 (-0.80%)

14:37
05/28/17
05/28
14:37
05/28/17
14:37
Conference/Events
TapImmune to hold a business update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SCOR

comScore

$24.80

-0.15 (-0.60%)

14:35
05/28/17
05/28
14:35
05/28/17
14:35
Conference/Events
comScore to host business news update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

BMY

Bristol-Myers

$53.97

-0.42 (-0.77%)

14:12
05/28/17
05/28
14:12
05/28/17
14:12
Conference/Events
Bristol-Myers to hold a pharmaceutical update conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 04

    Jun

  • 06

    Jun

  • 24

    Sep

LOXO

Loxo Oncology

$47.44

-0.06 (-0.13%)

14:10
05/28/17
05/28
14:10
05/28/17
14:10
Conference/Events
Loxo Oncology to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 04

    Jun

  • 06

    Jun

ADRO

Aduro Biotech

$10.05

-0.15 (-1.47%)

14:07
05/28/17
05/28
14:07
05/28/17
14:07
Conference/Events
Aduro Biotech to host analyst and investor meeting »

Management hosts special…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

ELGX

Endologix

$4.73

-0.05 (-1.05%)

14:06
05/28/17
05/28
14:06
05/28/17
14:06
Conference/Events
Endologix to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

  • 03

    Jun

TSRO

Tesaro

$149.11

-4.08 (-2.66%)

14:02
05/28/17
05/28
14:02
05/28/17
14:02
Conference/Events
Tesaro to hold an analyst and investor briefing »

Management hosts an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 03

    Jun

  • 30

    Jun

ICE

IntercontinentalExchange

$60.35

-0.09 (-0.15%)

13:57
05/28/17
05/28
13:57
05/28/17
13:57
Conference/Events
IntercontinentalExchange to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 07

    Jun

CPA

Copa Holdings

$111.69

0.2 (0.18%)

13:48
05/28/17
05/28
13:48
05/28/17
13:48
Conference/Events
Copa Holdings to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

CAH

Cardinal Health

$73.10

-0.34 (-0.46%)

13:31
05/28/17
05/28
13:31
05/28/17
13:31
Conference/Events
Cardinal Health to hold a meeting »

Dublin Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

BPMX

BioPharmX

$0.64

0.0089 (1.41%)

13:26
05/28/17
05/28
13:26
05/28/17
13:26
Conference/Events
BioPharmX holds state of acne symposium »

Management provides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.63

-0.72 (-0.89%)

13:20
05/28/17
05/28
13:20
05/28/17
13:20
Conference/Events
Novartis to hold a meeting »

Meet the Management Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 26

    Jun

CNC

Centene

$74.57

-0.68 (-0.90%)

, MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

12:34
05/27/17
05/27
12:34
05/27/17
12:34
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$74.57

-0.68 (-0.90%)

MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

HUM

Humana

$232.25

0.02 (0.01%)

AET

Aetna

$145.57

0.34 (0.23%)

ANTM

Anthem

$183.08

1.58 (0.87%)

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

WCG

WellCare

$172.97

0.15 (0.09%)

CI

Cigna

$161.32

-0.33 (-0.20%)

BX

Blackstone

$32.58

0.11 (0.34%)

NUE

Nucor

$58.15

-0.22 (-0.38%)

X

U.S. Steel

$19.74

-0.51 (-2.52%)

STLD

Steel Dynamics

$33.71

-0.73 (-2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 13

    Jun

  • 16

    Jun

21:00
05/26/17
05/26
21:00
05/26/17
21:00
General news
Breaking General news story  »

San Francisco Federal…

20:00
05/26/17
05/26
20:00
05/26/17
20:00
General news
Breaking General news story  »

San Francisco Federal…

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$9.79

-0.11 (-1.11%)

17:44
05/26/17
05/26
17:44
05/26/17
17:44
Syndicate
Breaking Syndicate news story on Daseke »

Daseke files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECYT

Endocyte

$2.47

0.02 (0.82%)

, RNN

Rexahn

$4.04

0.09 (2.28%)

17:35
05/26/17
05/26
17:35
05/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Endocyte (ECYT),…

ECYT

Endocyte

$2.47

0.02 (0.82%)

RNN

Rexahn

$4.04

0.09 (2.28%)

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

ECYT

Endocyte

$2.47

0.02 (0.82%)

17:33
05/26/17
05/26
17:33
05/26/17
17:33
Hot Stocks
Endocyte to announce updated data on EC1456, EC1169 at ASCO »

Endocyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.